Inge Marie Svane
Clinical Professor
- Published
The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy
Ahmad, S. M., Martinenaite, E., Holmström, M., Jørgensen, M. A., Met, Özcan, Nastasi, C., Klausen, U., dqp123, dqp123, Pedersen, Lars Møller, Munksgaard, Lars, Ødum, Niels, Woetmann, Anders , Svane, Inge Marie & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 2, 10 p., e1390641.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Harnessing PD-L1-specific cytotoxic T cells for anti-leukemia immunotherapy to defeat mechanisms of immune escape mediated by the PD-1 pathway
Ahmad, S. M., Larsen, S. K., Svane, Inge Marie & Andersen, M. H., Jan 2014, In: Leukemia. 28, 1, p. 236-238 3 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cancer treatment: the combination of vaccination with other therapies
Andersen, M. H., Sorensen, R. B., Schrama, D., Becker, J. C., Straten, P. T. & Svane, Inge Marie, 2008, In: Cancer Immunology, Immunotherapy. 57, 11, p. 1735-1743 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Indoleamine 2,3-dioxygenase vaccination
Andersen, Mads Hald & Svane, Inge Marie, 2015, In: OncoImmunology. 4, 1, p. 1-3 3 p., e983770.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients
Andersen, Mads Hald, Sørensen, R. B., Brimnes, M. K., Svane, Inge Marie, Becker, J. C. & thor Straten, P., 2009, In: Journal of Clinical Investigation. 119, 8, p. 2245-56 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Therapeutic cancer vaccines in combination with conventional therapy
Andersen, Mads Hald, Junker, N., Ellebaek, E., Svane, Inge Marie, Thor Straten, P. & Andersen, Mads Hald, 1 Jan 2010, In: Journal of Biomedicine and Biotechnology. 2010, p. 237623Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immunogenicity of Bcl-2 in patients with cancer
Andersen, M. H., Svane, Inge Marie, Kvistborg, P., Nielsen, O. J., Balslev, E., Reker, S., Becker, J. C. & Straten, P. T., 15 Jan 2005, In: Blood. 105, 2, p. 728-34 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression
Andersen, R., Borch, T. H., Draghi, A., Gokuldass, A., Rana, M. A. H., Pedersen, M., Nielsen, M., Kongsted, P., Kjeldsen, J. W., Westergaard, M. C. W., Radic, H. D., Chamberlain, C. A., Hølmich, Lisbet Rosenkrantz, Hendel, Helle Westergren, Larsen, M. S., Met, Özcan, Svane, Inge Marie & dqp123, dqp123, 2018, In: Annals of Oncology. 29, 7, p. 1575-1581 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma
Andersen, R., Donia, M., Westergaard, M. C. W., Pedersen, M., Hansen, M. & Svane, Inge Marie, 2015, In: Human Vaccines & Immunotherapeutics. 11, 12, p. 2790-5 6 p.Research output: Contribution to journal › Comment/debate › Research
- Published
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
Andersen, R., Donia, M., Ellebæk, E., Borch, T. H., Kongsted, P., Iversen, T. Z., Hølmich, Lisbet Rosenkrantz, Hendel, Helle Westergren, Met, Özcan, Andersen, Mads Hald, Thor Straten, E. P. & Svane, Inge Marie, Aug 2016, In: Clinical Cancer Research. 22, 15, p. 3734-3745 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell Therapy
Andersen, R., Westergaard, M. C. W., Kjeldsen, J. W., Müller, A., Pedersen, N. W., Hadrup, S. R., Met, Özcan, Seliger, B., Kromann-Andersen, B., Hasselager, T., dqp123, dqp123 & Svane, Inge Marie, 2018, In: Cancer Immunology Research. 6, 2, p. 222-235 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Late development of splenic sarcoidosis-like lesions in a patient with metastatic melanoma and long-lasting clinical response to ipilimumab
Andersen, R., Nørgaard, P. H., Al-Jailawi, M. K. M. & Svane, Inge Marie, 23 Jan 2014, In: OncoImmunology. 3, 8, e954506.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors
Andersen, R. S., Sørensen, R. B., Ritter, C., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2011, In: Cancer Immunology, Immunotherapy. 60, 2, p. 227-34 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Dissection of T-cell antigen specificity in human melanoma
Andersen, R. S., Albæk Thrue, C., Junker, N., Skou, R. B. L., Donia, M., Ellebæk, E., Svane, Inge Marie, Schumacher, T. N., Thor Straten, P. & Hadrup, S. R., 2012, In: Cancer Research. 72, 7, p. 1642-50 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome
Araujo B de Lima, V., Borch, A., Hansen, M., Draghi, A., Spanggaard, I., Rohrberg, K., Reker Hadrup, S., Lassen, Ulrik Niels & Svane, Inge Marie, Apr 2020, In: Cytotherapy. 22, 4, p. 204-213 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types
Araujo B. de Lima, V., Hansen, M., Spanggaard, I., Rohrberg, K., Reker Hadrup, S., Lassen, Ulrik Niels & Svane, Inge Marie, 25 Mar 2021, In: Frontiers in Oncology. 11, 11 p., 558248.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial
Ascierto, P. A., Long, G. V., Robert, C., Brady, B., Dutriaux, C., Di Giacomo, A. M., Mortier, L., Hassel, J. C., Rutkowski, P., McNeil, C., Kalinka-Warzocha, E., Savage, K. J., Hernberg, M. M., Lebbé, C., Charles, J., Mihalcioiu, C., Chiarion-Sileni, V., Mauch, C., Cognetti, F., Ny, L. & 8 others, , 2019, In: JAMA Oncology. 5, 2, p. 187-194Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
Ascierto, P. A., Del Vecchio, M., Robert, C., Mackiewicz, A., Chiarion-Sileni, V., Arance, A., Lebbé, C., Bastholt, L., Hamid, O., Rutkowski, P., McNeil, C., Garbe, C., Loquai, C., Dreno, B., Thomas, L., Grob, J-J., Liszkay, G., Nyakas, M., Gutzmer, R., Pikiel, J. & 10 others, , May 2017, In: Lancet Oncology. 18, 5, p. 611-622 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
Ascierto, P. A., Avallone, A., Bhardwaj, N., Bifulco, C., Bracarda, S., Brody, J. D., Buonaguro, L., Demaria, S., Emens, L. A., Ferris, R. L., Galon, J., Khleif, S. N., Klebanoff, C. A., Laskowski, T., Melero, I., Paulos, C. M., Pignata, S., Ruella, M., Svane, I. M., Taube, J. M. & 3 others, , 2022, In: Journal of Translational Medicine. 20, 1, 257.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
Ascierto, P. A., Ferrucci, P. F., Fisher, R., Del Vecchio, M., Atkinson, V., Schmidt, H., Schachter, J., Queirolo, P., Long, G. V., Di Giacomo, A. M., Svane, Inge Marie, Lotem, M., Bar-Sela, G., Couture, F., Mookerjee, B., Ghori, R., Ibrahim, N., Moreno, B. H. & Ribas, A., 2019, In: Nature Medicine. 25, 6, p. 941-946 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
Ascierto, P. A., Del Vecchio, M., Mackiewicz, A., Robert, C., Chiarion-Sileni, V., Arance, A., Lebbé, C., Svane, I. M., Mcneil, C., Rutkowski, P., Loquai, C., Mortier, L., Hamid, O., Bastholt, L., Dreno, B., Schadendorf, D., Garbe, C., Nyakas, M., Grob, J. J., Thomas, L. & 10 others, , 2020, In: Journal for ImmunoTherapy of Cancer. 8, 1, e000391.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort
Bastholt, L., Svane, Inge Marie, Bjerregaard, J. K., Herrstedt, Jørn, Hróbjartsson, A. & Schmidt, H., Jul 2019, In: European journal of cancer (Oxford, England : 1990). 115, p. 61-67Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Age favoured overall survival in a large population-based Danish patient cohort treated with anti-PD1 immune checkpoint inhibitor for metastatic melanoma
Bastholt, L., Schmidt, H., Bjerregaard, J. K., Herrstedt, Jørn & Svane, Inge Marie, Sep 2019, In: European journal of cancer (Oxford, England : 1990). 119, p. 122-131 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment
Bendtsen, S. K., Perez Penco, Maria, Hübbe, M. L., Martinenaite, E., Orebo Holmström, M., Weis-Banke, S. E., Grønne Dahlager Jørgensen, N., Jørgensen, M. A., Munir Ahmad, S., Jensen, K. M., Friese, C., Lundsager, M. T., Johansen, A. Z., Carretta, M., Ødum, Niels, Met, Özcan, Svane, Inge Marie, Madsen, Daniel Hargbøl & Andersen, Mads Hald, 2022, In: OncoImmunology. 11, 1, 2026020.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes
Bentzen, A. K., Marquard, A. M., Lyngaa, R., Saini, S. K., Ramskov, S., Donia, M., Such, L., Furness, A. J. S., McGranahan, N., Rosenthal, R., thor Straten, E. P., Szallasi, Z., Svane, Inge Marie, Swanton, C., Quezada, S. A., Jakobsen, S. N., Eklund, A. C. & Hadrup, S. R., Oct 2016, In: Nature Biotechnology. 34, 10, p. 1037-1045 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Increase of Circulating CD4(+)CD25(high)Foxp3(+) Regulatory T Cells in Patients With Metastatic Renal Cell Carcinoma During Treatment With Dendritic Cell Vaccination and Low-Dose Interleukin-2
Berntsen, A., Brimnes, M. K., Straten, P. T., Svane, Inge Marie, Berntsen, A., Brimnes, M. K., Straten, P. T. & Svane, Inge Marie, 2010, In: Journal of Immunotherapy. 33, 4, p. 425-434 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2
Berntsen, A., Brimnes, M. K., thor Straten, P. & Svane, Inge Marie, 2010, In: Journal of Immunotherapy. 33, 4, p. 425-34 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2
Bjoern, J., Brimnes, M. K., Andersen, Mads Hald, Straten, P. T. & Svane, Inge Marie, 2011, In: Scandinavian Journal of Immunology. 73, 3, p. 222-33 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with Ipilimumab
Bjoern, J., Juul Nitschke, N., Zeeberg Iversen, T., Schmidt, H., Fode, K. & Svane, Inge Marie, 2016, In: OncoImmunology. 5, 4, 10 p., e1100788.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
Bjoern, J., Lyngaa, R., Andersen, R., Hølmich, Lisbet Rosenkrantz, Hadrup, S. R., dqp123, dqp123 & Svane, Inge Marie, 2017, In: OncoTarget. 8, 16, p. 27062-27074Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab
Bjørn, J., Iversen, T. Z., Nitschke, N. J., Andersen, Mads Hald & Svane, Inge Marie, Aug 2016, In: Cytotherapy. 18, 8, p. 1043-1055 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
Bol, K. F., Ellebaek, E., Hoejberg, L., Bagger, M. M., Larsen, M. S., Klausen, T. W., Køhler, U. H., Schmidt, H., Bastholt, L., Kiilgaard, Jens Folke, dqp123, dqp123 & Svane, Inge Marie, 2019, In: Cancers. 11, 10, 11 p., 1489;.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Genetic biomarkers in melanoma of the ocular region: What the medical oncologist should know
Bol, K. F., dqp123, dqp123, Heegaard, Steffen, Kiilgaard, Jens Folke & Svane, Inge Marie, 2020, In: International Journal of Molecular Sciences . 21, 15, p. 1-14 14 p., 5231.Research output: Contribution to journal › Review › Research › peer-review
- Published
Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy
Borch, A., Bjerregaard, A. M., Araujo Barbosa de Lima, V., Østrup, O., Yde, C. W., Eklund, A. C., Mau-Sørensen, M., Barra, C., Svane, Inge Marie, Nielsen, Finn Cilius, Funt, S. A., Lassen, Ulrik Niels & Hadrup, S. R., 2023, In: Frontiers in Genetics. 14, 13 p., 1058605.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies
Borch, T. H., Donia, M., Andersen, Mads Hald & Svane, Inge Marie, Sep 2015, In: Drug Discovery Today. 20, 9, p. 1127-34 8 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma
Borch, T. H., Engell-Noerregaard, L., Iversen, T. Z., Ellebaek, E., Met, Özcan, Hansen, M., Andersen, Mads Hald, thor Straten, E. P. & Svane, Inge Marie, 1 Sep 2016, In: OncoImmunology. 5, 9, 12 p., e1207842.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
Borch, T. H., Andersen, R., Ellebaek, E., Met, Özcan, dqp123, dqp123 & Svane, Inge Marie, 2020, In: Journal for ImmunoTherapy of Cancer. 8, 2, e000668.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immune monitoring using mRNA-transfected dendritic cells
Borch, T. H., Svane, Inge Marie & Met, Özcan, 2016, Synthetic mRNA: Production, Introduction Into Cells, and Physiological Consequences. Humana Press, Vol. 1428. p. 245-259 15 p. (Methods in Molecular Biology, Vol. 1428).Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
- Published
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
Borch, T. H., Harbst, K., Rana, A. H., Andersen, R., Martinenaite, E., Kongsted, P., Pedersen, M., Nielsen, M., Kjeldsen, J. W., Kverneland, Anders Handrup, Lauss, M., Hølmich, Lisbet Rosenkrantz, Hendel, Helle Westergren, Met, Özcan, Jönsson, G., dqp123, dqp123 & Svane, Inge Marie, 2021, In: Journal for ImmunoTherapy of Cancer. 9, 7, 15 p., e00270.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Behandlingen af BRAF-muteret metastatisk melanom med BRAF/MEK-inhibitorer bedrer prognosen
Boyles, T. B., Svane, Inge Marie, Bastholt, L. & Schmidt, H., 2016, In: Ugeskrift for Laeger. 178, 4 p., V02160126.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR⿻/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma
Brimnes, M. K., Vangsted, Annette Juul, Knudsen, L. M., Gimsing, P., Gang, Uffe Jakob Ortved, Johnsen, H. & Svane, Inge Marie, 2010, In: Scandinavian Journal of Immunology. 72, 6, p. 540-7Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR⁻/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma
Brimnes, M. K., Vangsted, A. J., Knudsen, L. M., Gimsing, P., Gang, A. O., Johnsen, H. & Svane, Inge Marie, 1 Dec 2010, In: Scandinavian Journal of Immunology. 72, 6, p. 540-7 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion
Brimnes, M. K., Gang, A. O., Donia, M., Thor Straten, P., Svane, Inge Marie & Hadrup, S. R., 2012, In: Cancer Immunology, Immunotherapy. 61, 8, p. 1221-31 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial
Buch-Hansen, T. Z., Sørensen, R. B., Mellemgaard, A., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 919-920 2 p.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
Buschow, S. I., Ramazzotti, M., Reinieren-Beeren, I. M. J., Heinzerling, L. M., Westdorp, H., Stefanini, I., Beltrame, L., Hato, S. V., Ellebaek, E., Gross, S., Nguyen, V. A., Weinlich, G., Ragoussis, J., Baban, D., Schuler-Thurner, B., Svane, I. M., Romani, N., Austyn, J. M., De Vries, I. J. M., Schuler, G. & 2 others, , 2017, In: OncoTarget. 8, 40, p. 67439-67456 18 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Cabrita, R., Lauss, M., Sanna, A., Donia, M., Skaarup Larsen, M., Mitra, S., Johansson, I., Phung, B., Harbst, K., Vallon-Christersson, J., van Schoiack, A., Lövgren, K., Warren, S., Jirström, K., Olsson, H., Pietras, K., Ingvar, C., Isaksson, K., Schadendorf, D., Schmidt, H. & 5 others, , 2020, In: Nature. 577, p. 561-565Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cancer immunotherapy in patients with brain metastases
Caponnetto, S., Draghi, A., Borch, T. H., Nuti, M., Cortesi, E., Svane, Inge Marie & dqp123, dqp123, 2018, In: Cancer Immunology, Immunotherapy. 67, 5, p. 703-711 9 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Long-Term Exposure to Inflammation Induces Differential Cytokine Patterns and Apoptosis in Dendritic Cells
Carstensen, L. S., Lie-Andersen, O., Obers, A., Crowther, M. D., Svane, Inge Marie & Hansen, M., 2019, In: Frontiers in Immunology. 10, 11 p., 2702.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cells
Cathelin, D., Met, Özcan & Svane, Inge Marie, 2013, In: Cytotherapy. 15, 6, p. 740-749 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy
Chamberlain, C. A., Bennett, Eric Paul, Kverneland, Anders Handrup, Svane, Inge Marie, dqp123, dqp123 & Met, Özcan, 2022, In: Molecular Therapy - Oncolytics. 24, p. 417-428 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)
Chen, I. M., Donia, M., Chamberlain, C. A., Jensen, Agnete Witness Præst, Draghi, A., Theile, S., Madsen, K., Hasselby, Jane Preuss, Toxværd, A., Høgdall, Estrid Vilma Solyom, Lorentzen, T., Wilken, E. E., Geertsen, P., Svane, Inge Marie, Johansen, Julia Sidenius & Nielsen, D., 2023, In: European Journal of Cancer. 180, p. 125-133 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Randomized Phase II Study of Nivolumab with or Without Ipilimumab Combined with Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)
Chen, I. M., Johansen, Julia Sidenius, Theile, S., Hjaltelin, Jessica Xin, Novitski, Sif Ingibergsdóttir, Brunak, Søren, Hasselby, Jane Preuss, Willemoe, G. L., Lorentzen, T., Madsen, K., Jensen, B. V., Wilken, E. E., Geertsen, P., Behrens, C., Nolsøe, Christian, Hermann, K. L., Svane, Inge Marie & Nielsen, Dorte Lisbet, 2022, In: Journal of Clinical Oncology. 40, 27, p. 3180-3189Research output: Contribution to journal › Journal article › Research › peer-review
- Published
T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road
Crowther, M. D., Svane, Inge Marie & Met, Özcan, 2020, In: Cells. 9, 7, 18 p., 1588.Research output: Contribution to journal › Review › Research › peer-review
- Published
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1
Crowther, M. D., Dolton, G., Legut, M., Caillaud, M. E., Lloyd, A., Attaf, M., Galloway, S. A. E., Rius, C., Farrell, C. P., Szomolay, B., Ager, A., Parker, A. L., Fuller, A., dqp123, dqp123, McCluskey, J., Rossjohn, J., Svane, Inge Marie, Phillips, J. D. & Sewell, A. K., 2020, In: Nature Immunology. 21, 2, p. 178-185 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
Dafni, U., Michielin, O., Lluesma, S. M., Tsourti, Z., Polydoropoulou, V., Karlis, D., Besser, M. J., Haanen, J., Svane, Inge Marie, Ohashi, P. S., Kammula, U. S., Orcurto, A., Zimmermann, S., Trueb, L., Klebanoff, C. A., Lotze, M. T., Kandalaft, L. E. & Coukos, G., 2019, In: Annals of Oncology. 30, 12, p. 1902-1913 12 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours — Authors' reply
Dahl, E., Abed, O., Agnholt, J., Bjerrum, Jakob Tveiten , Dige, A., Kjeldsen, J., Svane, Inge Marie, Donia, M. & Seidelin, Jakob Benedict, 2023, In: Alimentary Pharmacology and Therapeutics. 57, 8, p. 918-919Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply
Dahl, E. K., Abed, O. K., Kjeldsen, J., dqp123, dqp123, Svane, Inge Marie, Dige, A., Agnholt, J. S., Bjerrum, Jakob Tveiten & Seidelin, Jakob Benedict, Jan 2023, In: Alimentary Pharmacology and Therapeutics. 57, 1, p. 152-153 2 p.Research output: Contribution to journal › Editorial › Research › peer-review
- Published
Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitis
Dahl, E. K., Abed, O. K., Kjeldsen, J., dqp123, dqp123, Svane, Inge Marie, Dige, A., Agnholt, J. S., Bjerrum, Jakob Tveiten & Seidelin, Jakob Benedict, 2022, In: Alimentary Pharmacology and Therapeutics. 56, 9, p. 1370-1382 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy
Dolton, G., Rius, C., Wall, A., Szomolay, B., Bianchi, V., Galloway, S. A. E., Hasan, M. S., Morin, T., Caillaud, M. E., Thomas, H. L., Theaker, S., Tan, L. R., Fuller, A., Topley, K., Legut, M., Attaf, M., Hopkins, J. R., Behiry, E., Zabkiewicz, J., Alvares, C. & 13 others, , 2023, In: Cell. 186, 16, p. 3333-3349.e27 45 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers
Dolton, G., Tungatt, K., Lloyd, A., Bianchi, V., Theaker, S. M., Trimby, A., Holland, C. J., Donia, M., Godkin, A. J., Cole, D. K., Straten, P. T., Peakman, M., Svane, Inge Marie & Sewell, A. K., Sep 2015, In: Immunology. 146, 1, p. 11-22 12 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Cancer immunotherapy in patients with preexisting autoimmune disorders
dqp123, dqp123, Pedersen, M. & Svane, Inge Marie, Apr 2017, In: Seminars in Immunopathology. 39, 3, p. 333-337 5 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
The real-world impact of modern treatments on the survival of patients with metastatic melanoma
dqp123, dqp123, Ellebaek, E., Øllegaard, T. H., Duval, L., Aaby, J. B., Hoejberg, L., Køhler, U. H., Schmidt, H., Bastholt, L. & Svane, Inge Marie, 2019, In: European Journal of Cancer. 108, p. 25-32 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials
dqp123, dqp123, Kimper-Karl, M. L., Høyer, K. L., Bastholt, L., Schmidt, H. & Svane, Inge Marie, 2017, In: European Journal of Cancer. 74, p. 89-95Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes
Donia, M., Ellebaek, E., Andersen, M. H., Straten, P. T. & Svane, Inge Marie, 2012, In: OncoImmunology. 1, 8, p. 1297-1304 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
IFN-γ to improve immunotherapy for melanoma
Donia, M., Svane, Inge Marie, Andersen, M. H., Hansen, M., Straten, P. T., Ellebæk, E., Iversen, T. Z. & SL, S., 2012. 0 p.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
- Published
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity
Donia, M., Andersen, R., Kjeldsen, J. W., Fagone, P., Munir, S., Nicoletti, F., Andersen, Mads Hald, Thor Straten, P. & Svane, Inge Marie, 15 Sep 2015, In: Cancer Research. 75, 18, p. 3747-59 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The controversial role of TNF in melanoma
Donia, M., Kjeldsen, J. W. & Svane, Inge Marie, 2016, In: OncoImmunology. 5, 4, 2 p., e1107699.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
PD-1+ Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for Cancer
dqp123, dqp123, Kjeldsen, J. W., Andersen, R., Westergaard, M. C. W., Bianchi, V., Legut, M., Attaf, M., Szomolay, B., Ott, S., Dolton, G., Lyngaa, R., Hadrup, S. R., Sewell, A. K. & Svane, Inge Marie, 2017, In: Clinical Cancer Research. 23, 19, p. 5779-5788Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Characterization and comparison of "Standard" and "Young" tumor infiltrating lymphocytes for adoptive cell therapy at a Danish Translational Research Institution
Donia, M., Junker, N., Ellebaek, E., Andersen, Mads Hald, Straten, P. T. & Svane, Inge Marie, 2012, In: Scandinavian Journal of Immunology. 75, 2, p. 157-167 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer
Donia, M., Fagone, P., Nicoletti, F., Andersen, R. S., Høgdall, E., Straten, P. T., Andersen, M. H. & Svane, Inge Marie, 2012, In: OncoImmunology. 1, 9, p. 1476-1483 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion
Donia, M., Hansen, M., Sendrup, S. L., Iversen, T. Z., Ellebæk, E., Andersen, M. H., Straten, P. T. & Svane, Inge Marie, 2013, In: Journal of Investigative Dermatology. 133, 2, p. 545-52 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling
Donia, M., Harbst, K., van Buuren, M., Kvistborg, P., Lindberg, M. F., Andersen, R., Idorn, M., Munir Ahmad, S., Ellebæk, E., Mueller, A., Fagone, P., Nicoletti, F., Libra, M., Lauss, M., Hadrup, S. R., Schmidt, H., Andersen, M. H., Thor Straten, P., Nilsson, J. A., Schumacher, T. N. & 3 others, , 1 Sep 2017, In: Cancer Research. 77, 17, p. 4562-4566 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Simplified protocol for clinical-grade tumor-infiltrating lymphocyte manufacturing with use of the Wave bioreactor
Donia, M., Larsen, S. M., Met, Özcan & Svane, Inge Marie, Aug 2014, In: Cytotherapy. 16, 8, p. 1117–1120 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Real-world evidence to guide healthcare policies in oncology
dqp123, dqp123, Hansen, S. W. & Svane, Inge Marie, 2019, In: OncoTarget. 10, 44, p. 4513-4515Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNϒ, Following Recognition of Autologous Tumor-Antigens
Draghi, A., Chamberlain, C. A., Khan, S., Papp, K., Lauss, M., Soraggi, S., Radic, H. D., Presti, M., Harbst, K., Gokuldass, A., Kverneland, Anders Handrup, Nielsen, M., Westergaard, M. C. W., Andersen, Mads Hald, Csabai, I., Jönsson, G., Szallasi, Z., Svane, Inge Marie & dqp123, dqp123, 2021, In: Frontiers in Immunology. 12, 13 p., 705422.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Uncoupling CD4þ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
Draghi, A., Presti, M., Jensen, A. W. P., Chamberlain, C. A., Albieri, B., Rasmussen, A. C. K., Andersen, M. H., Crowther, M. D., Svane, Inge Marie & Donia, M., 1 Oct 2023, In: Clinical Cancer Research. 29, 19, p. 3937-3947 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: implications for the management of irAEs
Draghi, A., Borch, T. H., Radic, H. D., Chamberlain, C. A., Gokuldass, A., Svane, Inge Marie & dqp123, dqp123, 2019, In: International Journal of Cancer. 145, 5, p. 1408-1413 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation
Duraiswamy, J., Turrini, R., Minasyan, A., Barras, D., Crespo, I., Grimm, A. J., Casado, J., Genolet, R., Benedetti, F., Wicky, A., Ioannidou, K., Castro, W., Neal, C., Moriot, A., Renaud-Tissot, S., Anstett, V., Fahr, N., Tanyi, J. L., Eiva, M. A., Jacobson, C. A. & 16 others, , 2021, In: Cancer Cell. 39, 12, p. 1623-1642.e20Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immune checkpoint inhibitor treatment and ophthalmologist consultations in patients with malignant melanoma or lung cancer—A nationwide cohort study
D’Souza, M., Bagger, M., Alberti, M., Malmborg, M., Schou, Morten, Torp-Pedersen, Christian, Gislason, Gunnar Hilmar, Svane, Inge Marie & Kiilgaard, Jens Folke, 1 Jan 2022, In: Cancers. 14, 1, 13 p., 49.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immune check point inhibitors are associated with a spectrum of cardiac events in patients with cancer
D’souza, M., Svane, Inge Marie, Gislason, Gunnar Hilmar & Schou, Morten, 21 Apr 2021, In: European Heart Journal. 42, 16, p. 1636-1636 1 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study
D’souza, M., Nielsen, Dorte Lisbet, Svane, Inge Marie, Iversen, Kasper, Rasmussen, P. V., Madelaire, C., Fosbøl, E., Køber, Lars Valeur, Gustafsson, Finn, Andersson, C., Gislason, Gunnar Hilmar, Torp-Pedersen, Christian & Schou, Morten, 2021, In: European Heart Journal. 42, 16, p. 1621-1631Research output: Contribution to journal › Journal article › Research › peer-review
- Accepted/In press
“One more chance to survive”: the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy—a qualitative study and recommendations for future care
Egeler, M. D., Boomstra, E., Rohaan, M. W., Van den Heuvel, N. M. J., Fraterman, I., Delfos, M., van de Poll-Franse, L. V., Borch, T. H., Svane, Inge Marie, Haanen, J. B. A. G., Retèl, V. P. & Boekhout, A. H., 2024, (Accepted/In press) In: Journal of Cancer Survivorship.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma
Eggermont, A. M. M., Meshcheryakov, A., Atkinson, V., Blank, C. U., Mandala, M., Long, G. V., Barrow, C., Di Giacomo, A. M., Fisher, R., Sandhu, S., Kudchadkar, R., Romero, P. L. O., Svane, I. M., Larkin, J., Puig, S., Hersey, P., Quaglino, P., Queirolo, P., Stroyakovskiy, D., Bastholt, L. & 14 others, , 2021, In: European Journal of Cancer. 158, p. 156-168 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The real-world outcome of metastatic melanoma: Unknown primary vs. known cutaneous
Ellebaek, E., Bastholt, L., Schmidt, H., Svane, Inge Marie & dqp123, dqp123, 1 Dec 2019, In: International Journal of Cancer. 145, 11, p. 3173-3174 2 p.Research output: Contribution to journal › Letter › Research › peer-review
- Published
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
Ellebaek, E., Iversen, T. Z., Junker, N., Donia, M., Engell-Noerregaard, L., Met, Özcan, Hølmich, Lisbet Rosenkrantz, Andersen, R. S., Hadrup, S. R., Andersen, M. H., Thor Straten, P. & Svane, Inge Marie, 2012, In: Journal of Translational Medicine. 10, p. 169Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immunotherapy for metastatic colorectal cancer: Present status and new options
Ellebaek, E., Andersen, M. H., Svane, Inge Marie & Straten, P. T., 2012, In: Scandinavian Journal of Gastroenterology. 47, 3, p. 315-24 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Clinical value of routine [18F]2-fluoro-2-deoxy-d-glucose positron emission tomography scans as a decision tool for early immunotherapy discontinuation in advanced melanoma
Ellebaek, E., Schina, A., Andersen, R., Hendel, Helle Westergren, Svane, Inge Marie & dqp123, dqp123, 2022, In: International Journal of Cancer. 150, 11, p. 1870-1878 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients
Ellebaek, E., Svane, Inge Marie, Schmidt, H., Haslund, C. A., dqp123, dqp123, Hoejberg, L., Ruhlmann, C., Guldbrandt, L. M., Køhler, U. H. & Bastholt, L., Aug 2021, In: Cancer Epidemiology. 73, 7 p., 101943.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Seasonal variation in effect of anti-PD-1 initiation on overall survival among patients with advanced melanoma
Ellebaek, E., Schina, A., Schmidt, H., Haslund, C. A., Bastholt, L., Svane, Inge Marie & dqp123, dqp123, 2023, In: Pigment Cell and Melanoma Research. 36, 2, p. 224-231Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
Ellebaek, E., Engell-Noerregaard, L., Iversen, T. Z., Moerch Froesig, T., Munir, S., Hadrup, S. R., Andersen, M. H. & Svane, Inge Marie, 2012, In: Cancer Immunology, Immunotherapy. 61, 10, p. 1791-1804 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Dendritic Cells Transfected with mRNA for p53, Survivin and hTERT as Treatment for Patients With Malignant Melanoma or Breast Cancer-A Phase I Study
Engell-Noerregaard, L., Hansen, T. H., Met, Ö., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876 1 p.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Combined Treatment with Dendritic Cell Vaccine and Low-Dose Cyclophosphamide in Patients with Malignant Melanoma
Engell-Noerregaard, L., Ellebaek, E., Buch-Hansen, T. Z., Nikolajsen, K., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876-877 2 p.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
FDG PET scans as evaluation of clinical response to dendritic cell vaccination in patients with malignant melanoma
Engell-Noerregaard, L., Hendel, H. W., Johannesen, H. H., Alslev, L. & Svane, Inge Marie, 2013, In: Cancer Immunology, Immunotherapy. 62, 1, p. 17-25 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters
Engell-Noerregaard, L., Hansen, T. H., Andersen, Mads Hald, Thor Straten, P. & Svane, Inge Marie, 2009, In: Cancer Immunology, Immunotherapy. 58, 1, p. 1-14 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma
Ferrucci, P. F., Di Giacomo, A. M., Del Vecchio, M., Atkinson, V., Schmidt, H., Schachter, J., Queirolo, P., Long, G. V., Stephens, R., Svane, Inge Marie, Lotem, M., Abu-Amna, M., Gasal, E., Ghori, R., Diede, S. J., Croydon, E. S., Ribas, A., Ascierto, P. A. & KEYNOTE-022 international team, K. I. T., 2020, In: Journal for ImmunoTherapy of Cancer. 8, 2, 8 p., e001806.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Comparison of efficacy in patients with metastatic melanoma treated with ipilimumab and nivolumab who did or did not discontinue treatment due to immune-related adverse events: A real-world data study
Fink, M., Vittrup, A. S., Bastholt, L., Svane, Inge Marie, dqp123, dqp123, Luczak, A. A., Ruhlmann, C. H., Guldbrandt, L. M., Koehler, U. H., Winther, M. L., Ellebaek, E., Haslund, C. A. & Schmidt, H., 2021, In: Cancers. 13, 21, 10 p., 5550.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immuncheckpointantistoffer øger overlevelsen for patienter med metastatisk melanom
Fløe, L. E., Svane, Inge Marie, Bastholt, L. & Schmidt, H., 2016, In: Ugeskrift for Laeger. 178, 4 p., V01160070.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
HER2 CAR-T cells eradicate uveal melanoma and T-cell therapy–resistant human melanoma in IL2 transgenic NOD/SCID IL2 receptor knockout mice
Forsberg, E. M. V., Lindberg, M. F., Jespersen, H., Alsen, S., Bagge, R. O., dqp123, dqp123, Svane, Inge Marie, Nilsson, O., Ny, L., Nilsson, L. M. & Nilsson, J. A., 2019, In: Cancer Research. 79, 5, p. 899-904 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer
Friese, C., Harbst, K., Borch, T. H., Westergaard, M. C. W., Pedersen, M., Kverneland, A., Jönsson, G., dqp123, dqp123, Svane, Inge Marie & Met, Özcan, 2020, In: Scientific Reports. 10, 1, 12 p., 3914.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Design and validation of conditional ligands for HLA-B*08:01, HLA-B*15:01, HLA-B*35:01, and HLA-B*44:05
Frøsig, T. M., Yap, J., Seremet, T., Lyngaa, R., Svane, Inge Marie, Thor Straten, P., Heemskerk, M. H. M., Grotenbreg, G. M. & Hadrup, S. R., Oct 2015, In: Cytometry. Part A. 87, 10, p. 967-75 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 4054758
Most downloads
-
277
downloads
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
257
downloads
T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
189
downloads
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
Research output: Contribution to journal › Journal article › Research › peer-review
Published